Mylan Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (40)

Latest Posts

About This Stock More About This Stock
Mylan Upgraded To Buy From Neutral At Citi
Article By: The Fly
Wednesday, August 16, 2017 5:54 AM EDT
Citi analyst Liav Abraham upgraded Mylan to Buy and raised her price target for the shares to $42 from $36.
In this article: MYL Also: ENDP, TEVA
Read
Mylan Continues Slide As Generic Price Slowdown Hits Results, Outlook
Article By: The Fly
Wednesday, August 9, 2017 2:03 PM EDT
Shares of Mylan are sliding after the company reported worse than expected earnings for the quarter and cut its financial outlook for 2017 and 2018, citing a price slowdown in generic drugs.
In this article: MYL Also: TEVA
Read
Mylan Misses On Q2 Earnings & Sales, Lowers View
Article By: Zacks Investment Research
Wednesday, August 9, 2017 11:00 AM EDT
Mylan N.V. reported disappointing second-quarter 2017 results wherein both earnings and sales missed estimates.
In this article: MYL Also: RHHBY, GSK, GILD
Read
Allergan Signals Higher Prices Potentially Ahead For Teva Pharmaceuticals
Article By: Dr. Duru
Tuesday, August 8, 2017 4:28 AM EDT
Teva Pharmaceuticals (TEVA) lost 24% last Thursday after reporting disappointing earnings. Investors clearly had no patience for any of this news.
In this article: AGN, MYL, TEVA
Read
Teva Q2 Earnings Lag, '17 View & Dividend Cut, Stock Slumps
Article By: Zacks Investment Research
Friday, August 4, 2017 7:38 AM EDT
Shares declined 24% on Thursday, hitting a 52-week low of $23.33 per share. In fact, shares have slumped 34.5% so far this year compared with the industry’s decline of 1.9%.
In this article: TEVA, NVS, AGN, MYL
Read

PARTNER HEADLINES

Latest Tweets for $MYL

No tweets yet!